Plain-English translation of NCT07459387 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This registry collects information from patients who undergo a catheter ablation procedure using the VOLT device—a new balloon-shaped catheter designed to treat atrial fibrillation (an irregular heart rhythm). Researchers want to understand how well this treatment works in everyday hospital settings across Europe and track how patients do after the procedure.
Atrial fibrillation can cause serious symptoms and complications, and doctors need new, effective ways to treat it. This study gathers real-world data to see how well this newer catheter approach performs compared to older methods and whether it helps patients feel better.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will undergo the catheter ablation procedure using the VOLT device at one of the participating European hospitals. Researchers will collect information about your procedure, how it goes, and any safety or effectiveness results. You will also be followed up after your procedure so doctors can track how you're doing and whether your symptoms improve.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Germany
Sponsor
Cardioangiologisches Centrum Bethanien
Enrollment target
~1,000 participants
Started
October 2025
Primary completion
October 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Boris Schmidt, Prof.Dr.med.
Cardioangiologisches Centrum Bethanien
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.